
New Alzheimer’s Treatment Targets cPLA2 Enzyme
USC scientists identified compounds that target cPLA2, an enzyme linked to Alzheimer's inflammation, especially in APOE4 gene carriers. This offers a potential new therapeutic approach for the disease.

USC scientists identified compounds that target cPLA2, an enzyme linked to Alzheimer's inflammation, especially in APOE4 gene carriers. This offers a potential new therapeutic approach for the disease.

Research links microplastic exposure to cognitive decline and Alzheimer's, especially in those with the APOE4 gene. Sex-dependent behavior changes observed in mice mirror human Alzheimer's patients.